|
|
 |
|
Home > Chemicals > Adhesives > Premium Company Profile: Royal DSM N.V.
|
| |
Premium Company Profile: Royal DSM N.V.
|
 |
|
|
Introduction
Royal DSM (DSM) is a diversified chemicals company, focusing on specialty products catering to the chemicals, nutrition and pharmaceutical industries. In September 2007, the company reviewed its 'Vision 2010', a strategic plan (2006-2010) by which it targets sales growth through innovation, increase sales in emerging markets and shifting its production to low-cost countries like China and India.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
DSM operates through four business segments: nutrition, pharma, performance materials, and industrial chemicals.
In November 2007, DSM and Crucell signed a non-exclusive PER.C6 technology research licensing agreement with Brazilian-based Recepta Biopharma. The agreement would allow Recepta Biopharma to use the PER.C6 technology to develop four antibodies it has licensed-in from the Ludwig Institute for Cancer Research.
DSM will expand its engineering plastics compounding capacity at the site in Jiangyin (China), which will be operational by the end of 2008. The investment is expected to increase the capacity of the compounding plant by 50%, and the added capacity will be operational towards the end of 2008.
Reasons to Purchase
Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization
|
|
 |
| |
|
|
| |
Published |
Price |
| 02/11/2008 |
|
 |
| |
Free Shipping Worldwide
 |
| |
|
|